VICARIOUS SRGCL INC A by Vicarious Surgical Inc. Analyst Price Targets - Benzinga

VICARIOUS SRGCL INC A by Vicarious Surgical Inc.

RBOTOTCPK

Trade with Public

Trade with Public

$0.0446

-1.88-97.68%

At close: Mar 16, 5:00 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare

VICARIOUS SRGCL INC A by Vicarious Surgical Inc. Analyst Price Targets

Wall Street analyst price targets and consensus rating for VICARIOUS SRGCL INC A by Vicarious Surgical Inc. (RBOT).

Price Target Range — 6 Quarters

Analyst Consensus — 3 Analysts

3Hold

Consensus RatingEqual-Weight# Analysts3Avg. Consensus PT$6Upside to Avg. PT+12913.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Dec 12, 2025	BTIG	Ryan Zimmerman	Suspends	Neutral	—
Aug 13, 2025	Piper Sandler	Adam Maeder	PT Cut	Neutral	$9→$7
Mar 18, 2025	Piper Sandler	Adam Maeder	PT Cut	Neutral	$11→$9
Nov 13, 2024	Piper Sandler	Adam Maeder	PT Cut	Neutral	$12→$11
Aug 13, 2024	Piper Sandler	Adam Maeder	Maintained	Neutral	$30→$12
Jul 15, 2024	Morgan Stanley	Patrick Wood	PT Cut	Equal-Weight	$18→$10
Mar 5, 2024	Piper Sandler	Adam Maeder	PT Cut	Neutral	$2→$1
Dec 4, 2023	Morgan Stanley	Patrick Wood	Initiate	Equal-Weight	$1
Nov 14, 2023	BTIG	Ryan Zimmerman	Downgrade	Buy→Neutral	—
Nov 14, 2023	Canaccord Genuity	Caitlin Cronin	Downgrade	Buy→Hold	$9→$0

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $7

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $8.5 to $7.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $8.5

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $10.5 to $8.5.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $10.5

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $12 to $10.5.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Adjusts Price Target To $12 from $30 (1-for-30 Reverse Stock Split)

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral, adjusts target to $12 from $30 (1-30 Reverse Stock Split)

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Vicarious Surgical, Lowers Price Target to $10

Morgan Stanley analyst Patrick Wood maintains Vicarious Surgical (NYSE:RBOT) with a Equal-Weight and lowers the price target from $18 to $10.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Neutral on Vicarious Surgical, Lowers Price Target to $1

Piper Sandler analyst Adam Maeder maintains Vicarious Surgical (NYSE:RBOT) with a Neutral and lowers the price target from $1.5 to $1.

Benzinga Newsdesk